Guardian Pharmacy Services, Inc. reported its financial results for the second quarter of 2025, revealing a revenue increase of 14.8% to $344.3 million compared to $300.0 million in the same period of 2024. For the six months ending June 30, 2025, revenue rose by 17.1% to $673.6 million, up from $575.4 million year-over-year. The company attributed this growth to both organic expansion and acquisitions, with approximately $30.1 million of the revenue increase for the six-month period stemming from acquisitions. The number of residents served also grew significantly, from 174,000 in June 2024 to 195,000 in June 2025, alongside an increase in prescriptions dispensed from 12.0 million to 13.7 million.
Despite the revenue growth, Guardian Pharmacy's net income for the second quarter decreased to $8.8 million, down from $15.8 million in the prior year. The decline was primarily due to increased selling, general, and administrative expenses, which rose by 25.5% to $55.6 million for the quarter, driven by higher employee headcount and share-based compensation costs. For the six-month period, net income was $18.1 million, compared to $22.9 million in the same period of 2024. The company also reported a provision for income taxes of $3.8 million for the quarter, reflecting its transition to corporate taxation following its IPO in September 2024.
Operationally, Guardian Pharmacy has expanded its footprint, now serving approximately 195,000 residents across 7,400 long-term care facilities in 38 states. The company completed several acquisitions in 2024 and 2025, which are expected to enhance its market position in the long-term care pharmacy sector. The total consideration for recent acquisitions amounted to $11.1 million, including cash and contingent payments based on future performance. The company continues to focus on integrating these acquisitions to drive organic growth and improve operational efficiencies.
Looking ahead, Guardian Pharmacy remains optimistic about its growth trajectory, supported by favorable industry trends such as an aging population and increasing demand for pharmacy services in assisted living and behavioral health facilities. The company plans to leverage its technology-enabled services to enhance patient care and reduce costs, positioning itself as a key player in the long-term care pharmacy market. Management indicated that they expect to continue expanding their service offerings and geographic reach, while also managing costs effectively to improve profitability in the coming quarters.
About Guardian Pharmacy Services, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.